Miralax and Xanthophyll drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Miralax (polyethylene glycol 3350) and Xanthophyll (lutein). Common drug interactions include abdominal distension among females and chest pain among males.

The phase IV clinical study analyzes what interactions people have when they take Miralax and Xanthophyll. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

What is Xanthophyll?

Xanthophyll has active ingredients of lutein. eHealthMe is studying from 72 Xanthophyll users. Check the latest studies of Xanthophyll.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

11 people who take Miralax and Xanthophyll together, and have interactions are studied.

Miralax and Xanthophyll drug interactions.

What are the common drug interactions of Miralax and Xanthophyll, by gender? *:

female:

Abdominal distension
Abdominal pain upper
Abnormal faeces (abnormal stool)
Adverse event
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Back pain
Cardiac arrest
Coma (state of unconsciousness lasting more than six hours)
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)

male:

Chest pain
Eructation (release of gas from the digestive tract)
Abdominal pain upper
Diarrhoea
Drug ineffective
Cardiac failure acute

What are the common drug interactions of Miralax and Xanthophyll, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blood electrolytes decreased
Drug effect decreased
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Insomnia (sleeplessness)
Pain
Rectal haemorrhage (bleeding from anus)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Spinal disorder (disease of spine a back bone)
Throat irritation

What are the existing conditions these people have? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 18.18%
Abnormal Faeces (abnormal stool): 2 people, 18.18%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 9.09%
Rickets (softening of bones): 1 person, 9.09%
Parkinson's Disease: 1 person, 9.09%
Pain: 1 person, 9.09%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Hypotension (abnormally low blood pressure): 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Miralax and Xanthophyll?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously